Edinburgh Research Explorer

Dr David Breen

Senior Clinical Research Fellow

  1. 2020
  2. Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson's disease

    Wijeyekoon, R. S., Kronenberg-Versteeg, D., Scott, K. M., Hayat, S., Kuan, W-L., Evans, J. R., Breen, D. P., Cummins, G., Jones, J. L., Clatworthy, M. R., Andres Floto, R., Barker, R. A. & Williams-Gray, C. H., Jul 2020, In : Brain, Behavior, and Immunity. 87

    Research output: Contribution to journalArticle

  3. Parkinson's Disease, NOTCH3 Genetic Variants, and White Matter Hyperintensities

    Ontario Neurodegenerative Disease Research Initiative Investigators, 23 Jun 2020, In : Movement Disorders.

    Research output: Contribution to journalArticle

  4. Impact of GBA1 variants on long-term clinical progression and mortality in incident Parkinson’s disease

    Stoker, T. B., Camacho, M., Winder-rhodes, S., Liu, G., Scherzer, C. R., Foltynie, T., Evans, J., Breen, D. P., Barker, R. A. & Williams-gray, C. H., 17 Apr 2020, In : Journal of Neurology, Neurosurgery & Psychiatry. p. jnnp-2020-322857

    Research output: Contribution to journalArticle

  5. Mild dopa-responsive dystonia in heterozygous tyrosine hydroxylase mutation carrier: Evidence of symptomatic enzyme deficiency? Response from the authors

    Lang, A. E., Bally, J. F., Breen, D. P., Schaake, S., Trinh, J., Rakovic, A. & Klein, C., 9 Apr 2020, In : Parkinsonism & Related Disorders.

    Research output: Contribution to journalArticle

  6. Cerebrospinal Fluid Cytokines and Neurodegeneration‐Associated Proteins in Parkinson's Disease

    Wijeyekoon, R. S., Moore, S. F., Farrell, K., Breen, D. P., Barker, R. A. & Williams‐gray, C. H., 4 Mar 2020, In : Movement Disorders.

    Research output: Contribution to journalArticle

  7. Progression of Neuropsychiatric Symptoms over Time in an Incident Parkinson’s Disease Cohort (ICICLE-PD)

    Dlay, J. K., Duncan, G. W., Khoo, T. K., Williams-gray, C. H., Breen, D. P., Barker, R. A., Burn, D. J., Lawson, R. A. & Yarnall, A. J., 2 Feb 2020, In : Brain Sciences. 10, 2, p. 78

    Research output: Contribution to journalArticle

  8. Mild dopa-responsive dystonia in heterozygous tyrosine hydroxylase mutation carrier: Evidence of symptomatic enzyme deficiency?

    Bally, J. F., Breen, D. P., Schaake, S., Trinh, J., Rakovic, A., Klein, C. & Lang, A. E., 30 Jan 2020, In : Parkinsonism & Related Disorders. 71, p. 44-45 2 p.

    Research output: Contribution to journalArticle

  9. 2019
  10. New awakenings: current understanding of sleep dysfunction and its treatment in Parkinson’s disease

    Keir, L. H. M. & Breen, D. P., 5 Dec 2019, In : Journal of Neurology.

    Research output: Contribution to journalComment/debate

  11. Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts

    International Parkinson's Disease Genomics Consortium, Dec 2019, In : Movement Disorders. 34, 12

    Research output: Contribution to journalArticle

  12. Physio4FMD: protocol for a multicentre randomised controlled trial of specialist physiotherapy for functional motor disorder

    Physio4FMD Collaborative Group, 21 Oct 2019, In : Bmc neurology. 19, 1, p. 242

    Research output: Contribution to journalArticle

Previous 1 2 3 4 5 6 7 8 Next